TFESI and Neuropathic Pain in Lumbosacral Radiculopathy

by palligoelme@gmail.com | Sep 2, 2026 | Clinical Trials

​ Conditions: Lumbosacral Radiculopathy; Neuropathic Pain From Lumbosacral Radiculopathy; Disc Herniation With Radiculopathy Interventions: Procedure: Transforaminal Epidural Steroid Injections Sponsors: Marmara University Recruiting Conditions: Lumbosacral...

A Clinical Trial of LBL-024 Combination Drug in Patients With Metastatic Colorectal Carcinoma

by palligoelme@gmail.com | Sep 2, 2026 | Clinical Trials

​ Conditions: Metastatic Colorectal Carcinoma Interventions: Drug: LBL-024 for Injection; Drug: Bevacizumab injection; Drug: Oxaliplatin injection; Drug: Capecitabine tablets; Drug: Fruquintinib Capsules Sponsors: Nanjing Leads Biolabs Co.,Ltd; Sun Yat-Sen University...

Effect of Guided Imagery on Sleep Quality, State Anxiety, and Comfort in Patients With Acute Coronary Syndrome

by palligoelme@gmail.com | Sep 2, 2026 | Clinical Trials

​ Conditions: Acute Coronary Syndromes (ACS) Interventions: Behavioral: Guided Imagery Sponsors: Afyonkarahisar Health Sciences University Not yet recruiting Conditions: Acute Coronary Syndromes (ACS) Interventions: Behavioral: Guided Imagery Sponsors: Afyonkarahisar...

Deep Iliacus Plane Block Versus Transmuscular Quadratus Lumborum Block for Postoperative Analgesia After Total Hip Arthroplasty

by palligoelme@gmail.com | Sep 2, 2026 | Clinical Trials

​ Conditions: Deep Iliacus Plane Block; Transmuscular Quadratus Lumborum Block; Postoperative Analgesia; Total Hip Arthroplasty Interventions: Drug: Deep iliacus plane block; Drug: Quadratus lumborum block Sponsors: Tanta University Recruiting Conditions: Deep Iliacus...

Phase 3 Study of INCB123667 Plus Bevacizumab Versus Bevacizumab Alone as First-Line Maintenance Therapy in Ovarian Cancer Overexpressing Cyclin E1

by palligoelme@gmail.com | Sep 1, 2026 | Clinical Trials

​ Conditions: Ovarian Cancer Interventions: Drug: INCB123667; Drug: Bevacizumab; Drug: Placebo Sponsors: Incyte Corporation Not yet recruiting Conditions: Ovarian Cancer Interventions: Drug: INCB123667; Drug: Bevacizumab; Drug: Placebo Sponsors: Incyte Corporation Not...